Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reform In Japan: Reviewers And Fees Go Up; Will Approval Times Go Down?

This article was originally published in The Gray Sheet

Executive Summary

U.S. device manufacturers hope an "action program" adopted by the Japanese government Dec. 17 and tied to increased industry user fees will significantly speed device approval times there

You may also be interested in...



Japan To Announce Medical Device Reimbursement Cuts In Coming Weeks

Companies selling medical devices in Japan will be notified in the next few weeks of payment rate reductions for their products following the recent release of reimbursement rules for the 2010-2012 cycle

Japan Will Announce Reimbursement Cuts In Coming Weeks

Companies selling medical devices in Japan will be notified in the next few weeks of payment rate reductions for their products following the recent release of reimbursement rules for the 2010-2012 cycle

Japan Will Announce Reimbursement Cuts In Coming Weeks

Companies selling medical devices in Japan will be notified in the next few weeks of payment rate reductions for their products following the recent release of reimbursement rules for the 2010-2012 cycle

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026929

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel